References

1. Couroux, P., Grosse, N., Salapatek, A. M., Goyal, Y., Pfaar, O., & Hohenfeld, I. P. (2023). Barrier-forming, drug-free nasal spray reduces allergic symptoms induced by house dust mite allergen. Clinical and Translational Allergy, https://doi.org/10.1002/clt2.12277
2. Salapatek, A. M., Pfaar, O., Couroux, P., Koitschev, A., Becker, S., & Meyer, T. (2023). Efficacy and tolerability of the barrier-forming drug-free nasal spray AM-301 in allergic rhinitis patients exposed to controlled grass pollen and house dust mite challenge. . Journal of Allergy and Clinical Immunology, https://doi.org/10.1016/j.jaci.2022.12.344
3. Becker, S., Deshmukh, S., De Looze, F., Francardo, V., Lee, J., McGirr, A., Nathan, Z., Rook, C., & Meyer, T. (2024). AM-301, a barrier-forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial. Allergy, https://doi.org/10.1111/all.16116
4. Sailer, M. M., Köllmer, M., Masson, B., Fais, F., Hohenfeld, I. P., & Herbig, M. E. (2023). Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray – AM-301. Drug Development and Industrial Pharmacy, 49(2), 275-286. https://doi.org/10.1080/03639045.2023.2183724